New arylamidas and arylimidas as potential cholinesterase inhibitors for treatment of Alzheimer's disease

被引：0
|
作者：
Cipres-Flores, Fabiola [1 ]
Trujillo-Ferrara, Jose [1 ]
Cuevas-Hernandez, Roberto [1 ]
Correa-Basurto, Jose [3 ]
Soriano-Ursua, Marvin [2 ]
机构：
[1] IPN, Escuela Super Med, Dept Biochem, Mexico City 07738, DF, Mexico
[2] IPN, Escuela Super Med, Dept Physiol, Mexico City 07738, DF, Mexico
[3] IPN, Escuela Super Med, Secc Estudios Posgrad & Invest, Lab Modelado Mol, Mexico City 07738, DF, Mexico
来源：
FASEB JOURNAL | 2014年 / 28卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
582.2
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A review on cholinesterase inhibitors for Alzheimer’s disease
    Preet Anand
    Baldev Singh
    Archives of Pharmacal Research, 2013, 36 : 375 - 399
  • [42] Cholinesterases and cholinesterase inhibitors in Alzheimer's disease
    Rakonczay, Z.
    Nagy, K.
    ACTA PHYSIOLOGICA HUNGARICA, 2009, 96 (01) : 116 - 117
  • [43] Cholinesterase inhibitors: beyond Alzheimer's disease
    Larner, A. J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (11) : 1699 - 1705
  • [44] Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease
    Hussein, Weiam
    Saglik, Beguem Nurpelin
    Levent, Serkan
    Korkut, Buesra
    Ilgin, Sinem
    Ozkay, Yusuf
    Kaplancikli, Zafer Asim
    MOLECULES, 2018, 23 (08)
  • [45] Value for money in treating Alzheimer's disease with the new cholinesterase inhibitors
    Shah, A
    Jenkins, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (01) : 45 - 47
  • [46] Novel N-benzylpiperidine carboxamide derivatives as potential cholinesterase inhibitors for the treatment of Alzheimer's disease
    van Greunen, Divan G.
    van der Westhuizen, C. Johan
    Cordier, Werner
    Nell, Margo
    Stander, Andre
    Steenkamp, Vanessa
    Panayides, Jenny-Lee
    Riley, Darren L.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 179 : 680 - 693
  • [47] Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment
    Makhaeva, Galina F.
    Lushchekina, Sofya V.
    Kovaleva, Nadezhda V.
    Astakhova, Tatiana Yu.
    Boltneva, Natalia P.
    Rudakova, Elena V.
    Serebryakova, Olga G.
    Proshin, Alexey N.
    Serkov, Igor V.
    Trofimova, Tatiana P.
    Tafeenko, Victor A.
    Radchenko, Eugene V.
    Palyulin, Vladimir A.
    Fisenko, Vladimir P.
    Korabecny, Jan
    Soukup, Ondrej
    Richardson, Rudy J.
    BIOORGANIC CHEMISTRY, 2021, 112
  • [48] Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease
    Samadi, Abdelouahid
    Chioua, Mourad
    Bolea, Irene
    de los Rios, Cristobal
    Iriepa, Isabel
    Moraleda, Ignacio
    Bastida, Agatha
    Esteban, Gerard
    Unzeta, Mercedes
    Galvez, Enrique
    Marco-Contelles, Jose
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 4665 - 4668
  • [49] Exploring Mannosylpurines as Copper Chelators and Cholinesterase Inhibitors with Potential for Alzheimer's Disease
    Schino, Ignazio
    Cantore, Mariangela
    de Candia, Modesto
    Altomare, Cosimo D.
    Maria, Catarina
    Barros, Joao
    Cachatra, Vasco
    Calado, Patricia
    Shimizu, Karina
    Freitas, Adilson A.
    Oliveira, Maria C.
    Ferreira, Maria J.
    Lopes, Jose N. C.
    Colabufo, Nicola A.
    Rauter, Amelia P.
    PHARMACEUTICALS, 2023, 16 (01)
  • [50] Cholinesterases in Alzheimer’s disease and Cholinesterase inhibitors in Alzheimer therapy
    Z. Rakonczay
    I. Kovács
    Acta Biologica Hungarica, 1998, 49 (1): : 55 - 70
12345